Our Report Series

Cancer Populations USA

Our Cancer Populations USA series of reports provides the most up-to-date and detailed description of cancer populations in the United States, with a 20-year epidemiological forecast of all key estimated populations. Key highlights included in each report are:

• A detailed description of the contemporary incident and recurrent/relapsed patient population in terms of its overall size, demographic (including racial and ethnic composition), stage at diagnosis, anatomical tumor subsites (where relevant), and histology.
• Individual US state-level estimates of the key populations (newly diagnosed incident cases and those eligible for first-line treatment of advanced disease), with ranking by patient population size and state-level risk.
• Prevalence of key genetic alterations within the population with advanced or relapsed disease and the corresponding patient population size.
• For all key populations, a detailed 20-year epidemiological forecast with a detailed description of forecast methods and assumptions.
• For each report, over 20 figures and tables, including heat maps, historical and forecast incidence by race and ethnicity, and demographic composition of the current and forecast newly diagnosed and advanced/relapsed disease populations.

To see for yourself, request a free sample report. If you’d like to see any other reports to freely appraise, please contact us.

Global Cancer Epidemiology Forecast

Our Global Cancer Epidemiology Forecast series of on-demand reports provides a comprehensive view of the current epidemiology, patient journey and current treatment across 10 high-income countries (Australia, Canada, France, Germany, Italy, Japan, South Korea, Spain, the UK and the USA).

Additionally, using a factor-based forecast model, we forecast the size and evolution of all key patient populations over a 20-year forecast period. Key highlights included in each report are:

• A detailed description of the current incident and recurrent/relapsed patient population in terms of size, clinical and demographic patient characteristics, tumor characteristics and current standard of care regimens across multiple lines of treatment.
• Prevalence of key genetic alterations within the population with advanced or relapsed disease and the corresponding patient population size.
• For all key populations, a detailed 20-year epidemiological forecast with a detailed description of forecast methods and assumptions.

Each report is customizable, and the delivery time is dependent on the included/excluded components. To discuss your needs, please contact us.